Alight (ALIT) Q3 2026 Earnings Call Transcript

Alight reported Q3 2026 revenue of $500 million, down 6.2% year over year, and adjusted EBITDA of $86 million versus $138 million a year earlier, while exceeding its internal expectations for both for the third consecutive quarter. It raised full-year revenue guidance midpoint to $2.120 billion from $2.088 billion and adjusted EBITDA midpoint to $415 million from $407.5 million. Management warned revenue is expected to decline further in 2027 as prior years’ weaker commercial execution flows through, with a return to growth anticipated in 2028; renewal retention improved to the high-90% range. Alight also acquired Abett after quarter-end and is deploying AI in customer service, while reporting $542 million in total liquidity and $1.991 billion in debt.

Analysis

The key distinction is retention versus replacement demand: high-90s renewal retention limits churn, but does not repair weak bookings, fee compression, or the 12–18-month lag before wins reach revenue. Management’s expected 2027 revenue decline therefore looks more consequential than this quarter’s beat. That beat leaned on project revenue and wealth volumes; management also cited cost timing, so it is weak evidence that recurring growth or normalized margins have bottomed. A further risk is defending renewals with pricing concessions: retention can improve while revenue quality deteriorates.

The upside case is a longer-dated commercial recovery, not near-term AI operating leverage. Call-routing claims are not yet quantified as durable savings, and Abett’s value depends on integration, client adoption, and converting health-data insights into paid expansion. BNY’s partnership may strengthen Alight’s wealth proposition, but is not evidence of material near-term revenue for either company.

Liquidity reduces immediate refinancing urgency, but roughly $2.0B of debt, declining year-to-date free cash flow versus last year, and an unsatisfactory lender process keep financing terms relevant ahead of the August 2028 maturity. In the next 1–3 months, watch 2027 guidance, renewal pricing/compression, and cash conversion; over 6–18 months, the test is whether bookings stabilize before the revenue lag rolls through. The contrarian risk to a bearish view is that retention and commercial execution are improving ahead of reported revenue, making the stock sensitive to credible proof points. No valuation or price data are provided, so avoid a target-based call.

Key Decisions for Investors

• Do not chase the quarterly beat. Consider a tactical short in ALIT on a relief rally, rather than an unconditional short at the open; the asymmetry is weaker if shares already price in the guided 2027 decline. A put spread is an alternative only after checking implied volatility and liquidity.
• Reassess after the next results: evidence of improving bookings/renewals without material fee concessions, stabilization in recurring revenue, and stronger cash conversion would falsify the near-term bearish thesis. A further guidance cut, persistent recurring-revenue decline, or weaker free cash flow would strengthen it.
• Track debt-market access as a catalyst, not an immediate liquidity crisis. Verify lender feedback, any refinancing terms, and cash generation against the August 2028 maturity; deteriorating credit terms would raise equity risk even if operating guidance holds.
• Treat AI and Abett as unproven options. Look for disclosed, repeatable service-cost reductions, integration costs, client adoption, and incremental contract value before attributing margin expansion or a growth premium.